INTI

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Inhibitor Therapeutics (INTI) Ownership - Who owns Inhibitor Therapeutics?

Inhibitor Therapeutics Inc is a pharmaceutical development company that is focused on developing and ultimately commercializing therapeutics based on already approved active pharmaceuticals that have patent-protected methods of use and/or methods of delivery for patients with certain cancers and certain non-cancerous proliferation disorders... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

4905 South West Shore Boulevard

Phone

+1 813 864-2562

Employees

Web

https://www.inhibitortx.com

Details

Group

Domestic Stock Funds

Fundamentals

INTI

Capitalization

9.48M

P/E Ratio

N/A

Risk (Beta)

-0.73

Dividend Yield

N/A

Total Cash

6.38M

Total Cash/Share

0.04

Total Debt

N/A

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

ROE

N/A

Book Value

3.41M

P/B Ratio

4.78

Cash Flow

N/A

Earnings

-0.02

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

17.2K

Current Ratio

144.78

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-3.07M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-38.42

Shares Held By Institutions

N/A

Shares Outstanding - Current

172M

Total Liabilities

3.05M

Total Volume MTD

N/A

Value

N/A

Gain YTD

-8.486

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology